Sign in / Join Now
ETFs & Funds
at current price there's not much downside, although it has considerable upside potential on any positive updates about Heplisav.
A loss is a loss no matter what the price. if they deliver results upside is the % who go with this new treatment vs current standard...
Add a reply...
Latest StockTalks »
people get DVAX breaking news and analysis by email alert.
Get email alerts on DVAX »
Dynavax Technologies Corporation
Get latest price
From other sites
Strength Seen in Dynavax (DVAX): Stock Gains 11.1%
at Zacks.com (Jan 25, 2016)
Dynavax Technologies : Presents Clinical Data From Lead Cancer Immunotherapy Candidate, SD-101, at ASH Annual Meeting
at 4-traders.com (Dec 5, 2015)
Dynavax Technologies : Initiates Immuno-Oncology Clinical Trial Evaluating SD-101 in Combination With Merck's Anti-PD-1 Therapy, KEYTRUDA(R) (pembrolizumab)
at 4-traders.com (Oct 8, 2015)
DYNAVAX TECHNOLOGIES : Other Events (form 8-K)
at 4-traders.com (Sep 15, 2015)
Dynavax Technologies (DVAX) Shares March Higher, Can It Continue?
at Zacks.com (Sep 14, 2015)